Theralase Technologies Stock Short Ratio
| TLTFF Stock | USD 0.19 0.01 5.00% |
Theralase Technologies fundamentals help investors to digest information that contributes to Theralase Technologies' financial success or failures. It also enables traders to predict the movement of Theralase OTC Stock. The fundamental analysis module provides a way to measure Theralase Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Theralase Technologies otc stock.
Theralase |
Theralase Technologies OTC Stock Short Ratio Analysis
Theralase Technologies' Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Theralase Technologies has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The short ratio for all United States stocks is 100.0% higher than that of the company.
Theralase Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Theralase Technologies' direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Theralase Technologies could also be used in its relative valuation, which is a method of valuing Theralase Technologies by comparing valuation metrics of similar companies.Theralase Technologies is currently under evaluation in short ratio category among its peers.
Theralase Fundamentals
| Return On Equity | -1.13 | |||
| Return On Asset | -0.59 | |||
| Operating Margin | (5.50) % | |||
| Current Valuation | 51.77 M | |||
| Shares Outstanding | 216.5 M | |||
| Shares Owned By Insiders | 2.56 % | |||
| Price To Earning | (9.16) X | |||
| Price To Book | 20.01 X | |||
| Price To Sales | 52.92 X | |||
| Revenue | 780.64 K | |||
| Gross Profit | 278.88 K | |||
| EBITDA | (4.13 M) | |||
| Net Income | (4.41 M) | |||
| Cash And Equivalents | 1.46 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 494.32 K | |||
| Debt To Equity | 0.19 % | |||
| Current Ratio | 2.49 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (4.03 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 12 | |||
| Beta | 1.92 | |||
| Market Capitalization | 61.59 M | |||
| Total Asset | 5.94 M | |||
| Z Score | 74.4 | |||
| Net Asset | 5.94 M |
About Theralase Technologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Theralase Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theralase Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theralase Technologies based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Theralase OTC Stock
Theralase Technologies financial ratios help investors to determine whether Theralase OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Theralase with respect to the benefits of owning Theralase Technologies security.